Necmettin AKDENİZ, Handan BİLEN, Mahmut Sami METİN, Ömer Faruk ELMAS

The potential role of human HIV-1 TAT-Interactive Protein 2 levels in the pathogenesis of contact dermatitis

Background/aim: Human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is a gene that is extensively expressed in human tissues as well as in tumor tissues. This study aimed to explore the potential role of HTATIP2/TIP30 in contact dermatitis (CD), which is one of the most common inflammatory cutaneous conditions. Materials and methods: This cross-sectional study involved adult patients with acute contact dermatitis who were admitted to the outpatient dermatology clinic of a tertiary hospital and healthy adult volunteers without any cutaneous or systemic diseases. The blood concentration of HTATIP2/TIP30 was measured using ELISA kits. Results: The research sample consisted of 31 patients with CD (18 males, 13 females) and 20 healthy control subjects (14 males, 6 females). The mean ages of the patients with CD and healthy volunteers were 37 and 30 years, respectively (p > 0.05). The mean value of serum HTATIP2/TIP30 levels in patients with CD was 1.65 ng ml–1, which is 0.60 ng ml–1 in the control group (p = 0.02) Conclusion: In this study, serum levels of HTATIP2/TIP30 were statistically significantly higher in patients with CD when compared to healthy controls. This outcome may indicate possible role of HTATIP2/TIP30 in the pathogenesis of CD.Key words: Contact dermatitis, CC3/TIP30, HTATIP2/TIP30

PDF

___

1. Fonacier L, Noor I. Contact dermatitis and patch testing for the allergist. Annals of Allergy, Asthma & Immunology 2018; 120 (6): 592-598. doi: 10.1016/j.anai.2018.03.003
2. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. European Journal of Dermatology 2009; 19 (4): 325-332. doi: 10.1684/ejd.2009.0686
3. Xiao H, Tao Y, Greenblatt J, Roeder RG. A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proceedings of the National Academy of Sciences of the United States of America 1998; 95 (5): 2146-2151. doi: 10.1073/ pnas.95.5.2146
4. Xiao H, Palhan V, Yang Y, Roeder RG. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. The European Molecular Biology Organization Journal 2000; 19 (5): 956-963. doi: 10.1093/emboj/19.5.956
5. Ito M, Jiang C, Krumm K, Zhang X, Pecha J et al. TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Research 2003; 63 (24): 8763-8767.
6. NicAmhlaoibh R, Shtivelman E. Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 2001; 20 (2): 270-275. doi: 10.1038/sj.onc.1204075
7. Shi M, Zhang X, Wang P, Zhang HW, Zhang BH et al. TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway. World Journal of Gastroenterology 2005; 11 (2): 221-227. doi: 10.3748/wjg.v11.i2.221
8. Shtivelman E. A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 1997; 14 (18): 2167-2173. doi: 10.1038/sj.onc.1201059
9. Zhao J, Zhang X, Shi M, Xu H, Jin J et al. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology 2006; 44 (1): 205-215. doi: 10.1002/hep.21213
10. Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest Journal 2002; 121 (4): 1278-1289. doi: 10.1378/ chest.121.4.1278
11. Franks AL, Slansky JE. Multiple Associations Between a Broad Spectrum of Autoimmune Diseases, Chronic Inflammatory Diseases and Cancer. Anticancer Research 2012; 32 (4): 1119– 1136.
12. Uzkeser H, Cadırcı E, Halıcı Z, Aydın S, Ozkanlar S et al. Human HIV 1 Tat Interactive Protein 2 As A Prognostic And or Diagnostic Factor For Ankylosing Spondylitis Rheumatoid Arthritis And Sarcoidosis. Acta Medica Mediterranea 2015; 31 (1): 115–120.
13. Zhang DH, Wong LL, Tai LK, Koay ES, Hewitt RE. Overexpression of CC3/TIP 30 is associated with HER-2/neu status in breast cancer. Journal of Cancer Research and Clinical Oncology 2005; 131 (9): 603-608. doi: 10.1007/s00432-005-0674-z
14. Elmas ÖF, Akdeniz N, Atasoy M, Karadag AS. Contact dermatitis: A great imitator. Clinics in Dermatology 2020; 38 (2): 176-192. doi: 10.1016/j.clindermatol.2019.10.003
15. Nassau S, Fonacier L. Allergic Contact Dermatitis. Medical Clinics of North America 2020; 104 (1): 61-76. doi: 10.1016/j. mcna.2019.08.012
16. Martins LEAM, Reis VMS. Immunopathology of allergic contact dermatitis. Anais Brasileiros de Dermatologia 2011; 86 (3): 419-433. doi: 10.1590/s0365-05962011000300001
17. Nelson JL, Mowad CM. Allergic Contact Dermatitis: Patch Testing Beyond the TRUE Test. The Journal of Clinical and Aesthetic Dermatology 2010; 3 (10): 36–41.
18. Dubey P. Reporter Gene Imaging of Immune Responses to Cancer: Progress and Challenges. Theranostics 2012; 2 (4): 355-362. doi: 10.7150/thno.3903
19. Kurulay F, Çavdar Z. İnflamatuar medyatörlere toplu bir bakış. Genel Tıp Dergisi 2006; 16 (3): 143-152.
20. King FW, Shtivelman E. Inhibition of nuclear import by the proapoptotic protein CC3. Molecular and Cellular Biology 2004; 24 (16): 7091-7101. doi: 10.1128/MCB.24.16.7091- 7101.2004
21. El Omari K, Bird LE, Nichols CE, Ren J, Stammers DK. Crystal structure of CC3 (TIP30): implications for its role as a tumor suppressor. Journal of Biological Chemistry 2005; 280 (18): 18229-18236. doi: 10.1074/jbc.M501113200
22. Zhao J, Lu B, Xu H, Tong X, Wu G et al. Thirty-kilodalton Tatinteracting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology 2008; 48 (1): 265-275. doi: 10.1002/hep.22280
23. Zhang H, Zhang Y, Duan HO, Kirley SD, Lin SX et al. TIP30 is associated with progression and metastasis of prostate cancer. International Journal of Cancer 2008; 123 (4): 810–816. doi: 10.1002/ijc.23638
24. Zheng ZJ, Fu J, Zhi F, Liu WJ, Guo YJ et al. The effects of interventional therapy on serum HTATIP2/TIP30, B7-H4 and short-term curative effect in primary hepatocellular carcinoma. European Review for Medical and Pharmacological Sciences 2018; 22 (20): 6778-6783. doi: 10.26355/eurrev_201810_16144
25. Engkilde K, Thyssen JP, Menné T, Johansen JD. Association between cancer and contact allergy: a linkage study. British Medical Journal Open. 2011; 1 (1): e000084. doi:10.1136/ bmjopen-2011-000084
26. Kırmaz C, Özentürk Ö. Malignitelere karşı gelişen immün yanıt. Astım Allerji İmmünoloji 2004; 2 (3): 167-174.
27. Zhang P, Chen Z, Chen L, Zang H, Zhu B et al. Clinical significance of changes in AFP, HTATIP2/TIP30, B7-H4 and inflammatory cytokines after transcatheter arterial chemoembolization. Journal of BUON 2020; 25 (2): 1206-1211.
28. Multhoff G, Molls M, Radons J. Chronic Inflammation in Cancer Development. Frontiers in Immunology 2011; 2: 98. doi: 10.3389/fimmu.2011.00098